IP Verse

Translate Bio patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Translate Bio opposed by its competitors

Explore Translate Bio's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2858679
Jun 5, 2024Pulmonary Delivery Of Mrna To Non-Lung Target Cells1
EP3501605
Jun 28, 2023Mrna Therapy For Argininosuccinate Synthetase Deficiency1
EP2970456
May 19, 2021Methods And Compositions For Delivering Mrna Coded Antibodies4
EP3336082
Apr 15, 2020Cleavable Lipids2
EP3134506
Aug 7, 2019Methods For Purification Of Messenger Rna2
EP3318248
Apr 10, 2019Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases2
EP2850189
Jan 23, 2019Compositions And Methods For Modulating Gene Expression1
EP3060303
Nov 14, 2018Mrna Therapy For Argininosuccinate Synthetase Deficiency1
EP3122878
Oct 24, 2018Mrna Therapy For The Treatment Of Ocular Diseases1
EP2506857
Feb 14, 2018Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases2

Top competitors of Translate Bio

List of top competitors of Translate Bio based on patent oppositions.